SCN2A and channelopathy: This classification does not fully characterize the channelopathy, especially where an estimated 20–30% of ASD/ID patients develop late-onset seizures in addition to SCN2A deficiency (Wolff et al., 2017; Sanders et al., 2018; Zhang et al., 2021).